Changes in causes of death in systemic sclerosis, Ann Rheum Dis, vol.66, pp.940-944, 1972. ,
Mapping and predicting mortality from systemic sclerosis, Ann Rheum Dis, vol.76, pp.1897-1905, 2017. ,
Determinants of morbidity and mortality of systemic sclerosis in Canada, Semin Arthritis Rheum, vol.39, pp.269-77, 2010. ,
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study, QJM, vol.103, pp.109-124, 2010. ,
Mortality and survival in systemic sclerosis: systematic review and meta-analysis, Semin Arthritis Rheum, vol.44, pp.208-227, 2014. ,
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and metaanalysis of cohort studies, Rheumatology, vol.51, pp.1017-1043, 2012. ,
Early mortality in a multinational systemic sclerosis inception cohort, Arthritis Rheumatol, vol.69, pp.1067-77, 2017. ,
Epidemiology of systemic sclerosis in northwest Greece, Semin Arthritis Rheum, vol.34, pp.714-734, 1981. ,
Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population, Rheumatology, vol.35, pp.1122-1128, 1996. ,
Mortality in systemic sclerosis: an international metaanalysis of individual patient data, Am J Med, vol.118, pp.2-10, 2005. ,
Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma), Rheumatology, vol.37, pp.750-755, 1998. ,
Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan, Scand J Rheumatol, vol.40, pp.373-381, 2011. ,
Mortality in systemic sclerosis (scleroderma), QJM, vol.82, pp.139-187, 1992. ,
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients, Medicine (Baltimore), vol.81, pp.139-53, 2002. ,
Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival, Medicine (Baltimore), vol.81, pp.154-67, 2002. ,
Survival and causes of death in 366 Hungarian patients with systemic sclerosis, Ann Rheum Dis, vol.67, pp.59-63, 2008. ,
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study, Rheumatology, vol.48, pp.304-312, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00422549
Clinical and genetic factors predictive of mortality in early systemic sclerosis, Arthritis Rheum, vol.61, pp.1403-1414, 2009. ,
Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital, Semin Arthritis Rheum, vol.39, pp.285-93, 2010. ,
The prognostic factors of systemic sclerosis for survival among Koreans, Clin Rheumatol, vol.29, pp.297-302, 2010. ,
Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients, J Rheumatol, vol.39, pp.1971-1979, 2012. ,
Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis, J Rheumatol, vol.40, pp.1127-1160, 2013. ,
Mortality in systemic sclerosis-a single centre study from the UK, Clin Rheumatol, vol.32, pp.1533-1542, 2013. ,
Early-versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients, Medicine (Baltimore), vol.93, pp.73-81, 2014. ,
The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis, Ann Rheum Dis, vol.73, pp.1060-1066, 2014. ,
Prediction of pulmonary complications and long-term survival in systemic sclerosis: pulmonary complications and survival in SSc, Arthritis Rheumatol, vol.66, pp.1625-1660, 2014. ,
The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies, Rheumatology, vol.51, pp.1027-1063, 2012. ,
, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheum, vol.23, pp.581-90, 1980.
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against rheumatism collaborative initiative: ACR/EULAR classification criteria for SSc, Arthritis Rheum, vol.65, pp.2737-2784, 2013. ,
Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, vol.29, pp.277-314, 2016. ,
Meta-analysis of observational studies in epidemiology: a proposal for reporting, JAMA, vol.283, pp.2008-2020, 2000. ,
The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis ,
Mortality in systemic sclerosis: a comparison with the general population, J Rheumatol, vol.22, pp.2100-2102, 1995. ,
Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study, Rheumatol Int, vol.37, pp.1101-1110, 2017. ,
Mortality and causes of death in a Swedish series of systemic sclerosis patients, Ann Rheum Dis, vol.57, pp.682-688, 1998. ,
Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum, vol.63, pp.1182-1191, 2011. ,
Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis, Rheumatology, vol.49, pp.1112-1119, 2010. ,
Retrospective studies in scleroderma: effect of potassium paraaminobenzoate on survival, J Clin Epidemiol, vol.41, pp.193-205, 1988. ,
Development of a five-year mortality model in systemic sclerosis patients by different analytical approaches, Clin Exp Rheumatol, vol.28, p.18, 2010. ,
Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis, Tissue Antigens, vol.69, pp.305-317, 2007. ,
Novel risk factors related to cancer in scleroderma, Autoimmun Rev, vol.16, pp.461-469, 2017. ,
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients, Rheumatology, vol.55, pp.315-324, 2016. ,
Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival, Rheumatol Int, vol.37, pp.75-84, 2017. ,
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature, Autoimmun Rev, vol.13, pp.1026-1060, 2014. ,
Race and association with disease manifestations and mortality in scleroderma, Medicine (Baltimore), vol.92, pp.191-205, 2013. ,
The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis, Rheumatology, vol.42, pp.534-574, 2003. ,
Prevalence, progn,osis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis, Clin Exp Rheumatol, vol.30, p.30, 2012. ,
The effect of male sex on survival in systemic sclerosis, J Rheumatol, vol.41, pp.2193-200, 2014. ,
Impact of cardiac involvement on the risk of mortality among patients with systemic sclerosis: a 5-year follow-up of a single-center cohort, Clin Rheumatol, vol.33, pp.197-205, 2014. ,
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population, Arthritis Rheum, vol.48, pp.2246-55, 2003. ,
Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran, Rheumatol Int, vol.36, pp.925-959, 2016. ,
Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis, J Med Assoc Thail Chotmaihet Thangphaet, vol.85, pp.1204-1213, 2002. ,
Mortality and prognostic factors in Spanish patients with systemic sclerosis, Rheumatology, vol.42, pp.71-76, 2003. ,
Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death, Medicine (Baltimore), vol.94, p.1728, 2015. ,
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis, Arthritis Rheum, vol.64, pp.2986-94, 2012. ,
Life expectancy at birth, 2017. ,
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres, Ann Rheum Dis, vol.70, pp.1788-92, 2011. ,
Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit, Arthritis Rheum, vol.42, pp.2660-2665, 1999. ,
Whole-body distribution and clinical association of Telangiectases in systemic sclerosis, JAMA Dermatol, vol.154, pp.796-805, 2018. ,
Factors associated with the 6-minute walk distance in patients with systemic sclerosis, Arthritis Res Ther, vol.19, pp.279-90, 2017. ,
Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis, Arthritis Rheum, vol.65, pp.2412-2435, 2013. ,
Troponin I and echocardiography in patients with systemic sclerosis and matched population controls, Scand J Rheumatol, vol.46, pp.226-261, 2017. ,
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis, Ann Rheum Dis, vol.67, pp.31-37, 2008. ,
Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies, Arthritis Rheum, vol.65, pp.1913-1934, 2013. ,
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, Ann Rheum Dis, vol.69, pp.1809-1824, 2010. ,
Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies, Arthritis Rheum, vol.62, pp.2787-95, 2010. ,
Adjusting for multiple testing-when and how?, J Clin Epidemiol, vol.54, pp.343-352, 2001. ,